Literature DB >> 11980627

New somatostatin analogs: will they fulfil old promises?

S W J Lamberts1, A J van der Lely, L J Hofland.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11980627     DOI： 10.1530/eje.0.1460701

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN： 0804-4643            Impact factor:   6.664


× No keyword cloud information.
  17 in total

1.  Characterization of agonist-dependent somatostatin receptor subtype 2 trafficking in neuroendocrine cells.

Authors:  Walaa Alshafie; Yingzhou Edward Pan; Hans-Jürgen Kreienkamp; Thomas Stroh
Journal:  Endocrine       Date:  2020-05-07       Impact factor: 3.633

2.  Correlation of monoclonal and polyclonal somatostatin receptor 5 antibodies in pancreatic neuroendocrine tumors.

Authors:  Daniel Kaemmerer; Amelie Lupp; Luisa Peter; Elke Fischer; Stefan Schulz; Günter Klöppel; Merten Hommann
Journal:  Int J Clin Exp Pathol       Date:  2012-11-20

3.  The early diagnosis of multiple endocrine neoplasia type 1 (MEN 1): a case report.

Authors:  G Tamagno; E De Carlo; C Martini; D Rubello; F Fallo; N Sicolo
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

4.  Congenital Chylothorax of the Newborn: A Systematic Analysis of Published Cases between 1990 and 2018.

Authors:  Bernhard Resch; Gülsen Sever Yildiz; Friedrich Reiterer
Journal:  Respiration       Date:  2021-09-01       Impact factor: 3.580

Review 5.  Somatostatin and somatostatin receptor physiology.

Authors:  Philip Barnett
Journal:  Endocrine       Date:  2003-04       Impact factor: 3.633

Review 6.  Somatostatin receptors in pituitary and development of somatostatin receptor subtype-selective analogs.

Authors:  Ilan Shimon
Journal:  Endocrine       Date:  2003-04       Impact factor: 3.633

7.  Ring size of somatostatin analogues (ODT-8) modulates receptor selectivity and binding affinity.

Authors:  Judit Erchegyi; Christy Rani R Grace; Manoj Samant; Renzo Cescato; Veronique Piccand; Roland Riek; Jean Claude Reubi; Jean E Rivier
Journal:  J Med Chem       Date:  2008-04-12       Impact factor: 7.446

8.  Acromegaly: correlation between expression of somatostatin receptor subtypes and response to octreotide-lar treatment.

Authors:  Ana Paula M Casarini; Raquel S Jallad; Emília M Pinto; Iberê C Soares; Suely Nonogaki; Daniel Giannella-Neto; Nina R Musolino; Venâncio A F Alves; Marcello D Bronstein
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

9.  Impact of Octreotide and SOM-230 on liver metastasis and hepatic lipidperoxidation in ductal pancreatic adenocarcinoma in Syrian Hamster.

Authors:  M Kilian; J I Gregor; I Heukamp; K Helmecke; M Hanel; B Wassersleben; M K Walz; I Schimke; G Kristiansen; F A Wenger
Journal:  Clin Exp Metastasis       Date:  2009-06-12       Impact factor: 5.150

10.  Medical therapy of acromegaly.

Authors:  U Plöckinger
Journal:  Int J Endocrinol       Date:  2012-04-10       Impact factor: 3.257
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.